ICLE 发表于 2025-3-23 10:20:52

http://reply.papertrans.cn/19/1877/187656/187656_11.png

Cholagogue 发表于 2025-3-23 14:48:43

https://doi.org/10.1007/978-3-663-08632-1nal gammopathy of renal significance (MGRS) has been introduced to distinguish these patients from those with the benign monoclonal gammopathy of undetermined significance. Kidney diseases of MGRS can be classified according to the type of deposits in the kidney. The three major categories are organ

两栖动物 发表于 2025-3-23 19:29:11

http://reply.papertrans.cn/19/1877/187656/187656_13.png

BUST 发表于 2025-3-24 02:12:08

Book 2017globin deposition disease, and cryoglobulinemic syndromes, among others. The only book dedicated to this intriguing family of diseases, .Biology and Management of Unusual Plasma Cell Dyscrasias. will be a long-lasting reference for clinicians and scientists alike..

ETHER 发表于 2025-3-24 03:39:33

Sabine Lorenz,Kai Wegrich,Hellmut Wollmannhave an excellent prognosis with local therapies; outcomes are less good, and therapies are less well established for the patients with multicentric CD with the exception of interleukin-6 and interleukin-6 receptor antibodies, which are useful in a subset of patients.

地名表 发表于 2025-3-24 09:29:48

http://reply.papertrans.cn/19/1877/187656/187656_16.png

初次登台 发表于 2025-3-24 13:12:25

https://doi.org/10.1007/978-3-663-08632-1ransplantation. This requires confirmation that a MGRS is responsible for the disease, which can only be done by a kidney biopsy. The treatment should optimally target the clone producing the MGRS rather than be based on renal histology.

Fabric 发表于 2025-3-24 15:50:28

,Waldenstrom’s Macroglobulinemia,an be complex as many patients do not require treatment initially. When patients do require therapy, it is important to select therapies that do not limit future treatment options. To provide a simple risk-adapted approach to managing patients with Waldenstrom’s macroglobulinemia, a rational approach to this disease is presented.

anaphylaxis 发表于 2025-3-24 19:04:59

Renal Disease Associated with Monoclonal Gammopathy,ransplantation. This requires confirmation that a MGRS is responsible for the disease, which can only be done by a kidney biopsy. The treatment should optimally target the clone producing the MGRS rather than be based on renal histology.

歌剧等 发表于 2025-3-25 02:26:39

http://reply.papertrans.cn/19/1877/187656/187656_20.png
页: 1 [2] 3 4 5
查看完整版本: Titlebook: Biology and Management of Unusual Plasma Cell Dyscrasias; Todd M. Zimmerman,Shaji K. Kumar Book 2017 Springer Science+Business Media New Y